You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drugs Containing Excipient (Inactive Ingredient) POLYETHYLENE GLYCOL 400


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYETHYLENE GLYCOL 400 excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
ER Squibb & Sons LLC BARACLUDE entecavir 0003-1611 POLYETHYLENE GLYCOL 400
Eli Lilly and Company EVISTA raloxifene hydrochloride 0002-4184 POLYETHYLENE GLYCOL 400
Genentech Inc VALCYTE valganciclovir 0004-0038 POLYETHYLENE GLYCOL 400
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 3 of 3 entries

Polyethylene Glycol 400: Market Dynamics and Financial Trajectory

Market Overview

Polyethylene Glycol 400 (PEG 400), a versatile and widely used polymer, is experiencing significant growth driven by its diverse applications across various industries. Here’s a detailed look at the market dynamics and financial trajectory of PEG 400, particularly in the context of its use as a pharmaceutical excipient.

Current Market Size and Growth Projections

As of 2024, the global polyethylene glycol market, which includes PEG 400, is valued at USD 4,284.0 million. This market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.4% from 2024 to 2034, reaching a valuation of USD 7,999.4 million by 2034[1][2].

Pharmaceutical Sector Dominance

The pharmaceutical sector remains the largest application segment for PEG 400, contributing over 35% to the market revenue in 2024. This dominance is due to the widespread use of PEG 400 as an excipient in drug formulations, including laxatives, drug carriers, and controlled-release medications[1][2].

Key Drivers of Growth

Pharmaceutical Innovations

The adoption of PEG 400 in advanced drug delivery systems is a significant driver of growth. Its use in formulations such as tablet binders, fillers, and topical preparations enhances the stability and efficacy of drugs. The increasing focus on patient-specific medicines and new drug development further solidifies the demand for PEG 400[1][2].

Personal Care and Cosmetics

The personal care and cosmetics industry also drives demand for PEG 400 due to its emollient and humectant properties. Rising consumer awareness about skincare and haircare has led to an increased use of PEG 400 in various cosmetic and toiletry products[1][2].

Sustainability Push

There is a growing trend towards sustainability, with manufacturers prioritizing biodegradable and bio-based polyethylene glycol formulations. This shift aligns with global environmental goals and consumer preferences, contributing to the market's growth trajectory[1][2].

Regional Growth Analysis

North America

North America dominates the polyethylene glycol market, driven by strong demand in pharmaceuticals and cosmetics. The robust research and development infrastructure in this region supports continuous product innovation[1].

Asia-Pacific

The Asia-Pacific region is poised to be the fastest-growing market, driven by rapid industrialization and the expansion of pharmaceutical and personal care industries in countries like China and India. This region's growth is expected to be significant, with countries like India and China showing CAGRs of 6.3% and 7.3%, respectively, from 2024 to 2034[1].

Europe

Europe is witnessing steady growth, primarily due to stringent environmental regulations favoring bio-based PEG products. This regulatory environment encourages the development and use of sustainable PEG formulations[1].

Challenges and Restraints

Raw Material Price Volatility

The prices of ethylene oxide, a key raw material for manufacturing PEG 400, are volatile due to global supply and demand scenarios, as well as macroeconomic factors. This volatility impacts manufacturing costs and can hinder market growth[2].

Stringent Regulations

The introduction of stringent environmental and quality regulations, especially for pharmaceutical and food applications, requires significant investments in research and development. Smaller manufacturers may struggle to absorb these costs, which can act as a restraint to market growth[2].

Product Type and Form

Liquid PEG 400

Liquid PEG 400 is the most widely used form, holding a 54.9% share in the market. Its versatility across various applications, including pharmaceuticals, cosmetics, and personal care, drives its demand. Liquid PEG 400 is available in different molecular weights such as PEG 200, PEG 300, and PEG 400, making it an excellent solvent and humectant[2].

Financial Trajectory

The financial trajectory of the polyethylene glycol market, including PEG 400, is promising. Here are some key financial highlights:

  • Current Valuation: The market is valued at USD 4,284.0 million in 2024.
  • Growth Rate: Expected to grow at a CAGR of 6.4% from 2024 to 2034.
  • Projected Valuation: To reach USD 7,999.4 million by 2034[1][2].

Industry Trends and Future Outlook

Technological Advancements

Innovations in production techniques are improving the efficiency and environmental compatibility of PEG 400. These advancements are crucial for meeting the increasing demand for sustainable products[1].

Sustainability Focus

The trend towards sustainability is predominant, with a focus on developing biodegradable and bio-based alternatives to PEG 400. This aligns with global environmental goals and consumer preferences, driving competition and investment in greener PEG solutions[1][2].

Regulatory Compliance

Manufacturers are increasingly focusing on compliance with stringent environmental and quality regulations. This includes the development of innovative grades of PEG 400 for high-performance industrial applications[1].

Key Takeaways

  • Market Growth: The polyethylene glycol market, including PEG 400, is expected to grow at a CAGR of 6.4% from 2024 to 2034.
  • Pharmaceutical Dominance: The pharmaceutical sector remains the largest application segment for PEG 400.
  • Sustainability: There is a growing focus on biodegradable and bio-based PEG formulations.
  • Regional Growth: Asia-Pacific is the fastest-growing region, driven by industrial growth in India and China.
  • Challenges: Raw material price volatility and stringent regulations are key challenges.

FAQs

What is the current market size of the polyethylene glycol market?

The polyethylene glycol market is valued at USD 4,284.0 million in 2024[1][2].

What is the expected CAGR of the polyethylene glycol market from 2024 to 2034?

The market is expected to grow at a CAGR of 6.4% from 2024 to 2034[1][2].

Which region is the fastest-growing market for polyethylene glycol?

The Asia-Pacific region is the fastest-growing market, driven by strong industrial growth in India and China[1].

What are the primary applications of PEG 400?

PEG 400 is primarily used in pharmaceuticals, personal care products, and industrial applications[1][2].

What are the key challenges facing the polyethylene glycol market?

Raw material price volatility and stringent environmental and quality regulations are key challenges[2].

Sources

  1. GlobeNewswire: Polyethylene Glycol Market Trends Highlight Robust Demand and USD 7,999.4 million Valuation by 2034 - Future Market Insights Inc.[1]
  2. Future Market Insights: Polyethylene Glycol Market Insights by Form & Application to 2034[2]
  3. ResearchAndMarkets: Pharmaceutical Excipients Global Market Report 2024[3]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.